“Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL

A discovery-phase urine proteomics investigation in type 1 diabetes

(2012) A. Soggiu et al.   ACTA DIABETOLOGICA

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy

(2011) Stine E. Nielsen et al.   KIDNEY INTERNATIONAL

Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality

(2010) Lixin Guo et al.   ACTA DIABETOLOGICA

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

(2010) S. E. Nielsen et al.   DIABETES CARE

From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology

(2010) D. Bolignano et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease

(2009) D. Bolignano et al.   Clinical Journal of the American Society of Nephrology

Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study

(2009) P. Hovind et al.   DIABETES

Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients

(2009) Davide Bolignano et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons

(2009) Takashige Kuwabara et al.   KIDNEY INTERNATIONAL

Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage

(2008) Davide Bolignano et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Uric acid: bystander or culprit in hypertension and progressive renal disease?

(2008) Paolo Menè et al.   JOURNAL OF HYPERTENSION

Neutrophil Gelatinase-Associated Lipocalin Reflects the Severity of Renal Impairment in Subjects Affected by Chronic Kidney Disease

(2008) Davide Bolignano et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease

(2008) JOLANTA MALYSZKO et al.   NEPHROLOGY